Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes.
Saved in:
| Title: | Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes. |
|---|---|
| Authors: | Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Natu A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Gurney M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Fathima S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Alsugair AKA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Bazinet A; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Chien K; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hammond D; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., DiNardo C; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Kadia T; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Ravandi-Kashani F; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Pemmaraju N; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Sasaki K; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Finke CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Begna K; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Hefazi Torghabeh M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Matin A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Saliba AN; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Garcia-Manero G; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Kantarjian HM; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, 33612, USA., Xie Z; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, 33612, USA., Ali NA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, 33612, USA., Sallman D; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, 33612, USA., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, 33612, USA., Montalban-Bravo G; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA. patnaik.mrinal@mayo.edu. |
| Source: | Leukemia [Leukemia] 2025 Aug; Vol. 39 (8), pp. 2030-2034. Date of Electronic Publication: 2025 Jun 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
